Drug Delivery Technologies Market By Application (Oral, Pulmonary, Transdermal, Injectable, Nasal, Implantable & Others) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

Various drug delivery technologies assist in adjusting dosage release with the best possible safety and efficacy. Drug delivery technologies simplify the challenge of patient compliance, facilitate precision in dosage and reduce side effects. For this study, the global drug delivery devices market is studied in terms of mode of administration and geography.

In terms of mode of administration, the global drug delivery devices market is categorized into oral, pulmonary, injectable, nasal, implantable, ocular, buccal, etc., segments. Each of these segments is studied for its current market status and prospect. Market size and forecast (in terms of USD Bn) for 2014 to 2022, with compounded annual growth rate (CAGR %) for 2016 to 2022.

Geographically, North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa together form the global drug delivery technologies market. Similar to segmentation by mode of administration, the geographic markets are also studied in terms of their current and future market value. Market revenue and forecast for 2014 to 2022, along with the respective CAGRs for 2016 to 2022, are provided in this report for each respective regional market and certain key national markets.

For further elucidation, the regional market segmentation is represented as follows:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Rest of Asia-Pacific
  • The Middle East and North Africa
  • Latin America

Apart from market size and forecast in this report on the global drug delivery market, this report also includes qualitative information sets such as market dynamics information: drivers, challenges, and prospects. Fractal map analysis for analyzing the overall market competition and attractive investment proposition tools are also included in the study. This report concludes with a company profiles section highlighting key information about the major market players operating in the global drug delivery technologies market.

Oral, injectable, implantable, pulmonary, transdermal, nasal, ocular, buccal, and others are the prime segments of the drug delivery technologies market. Oral and injectable administrations are the oldest modes of drug delivery and together took over 55% of the market share in 2015. The two modes represent the widest range of drugs in the pharmaceutical market and are the most affordable methods accepted worldwide.

Major factors determining the growth of this market are the growing incidence of chronic diseases, rapid innovation, technological development, and the ongoing growth of the biologics market. Additionally, the demand for transdermal delivery methods is estimated to flourish during the forecast period. Convenience in use, ease of self-administration, the accuracy of delivering the right dosage at the right location, and painless drug delivery are the prime factors contributing to the growth of the transdermal drug delivery segment.

The implantable drug delivery segment will undergo the fastest growth during the forecast period. Specific site drug administration, reduction in the burden of patient compliance, and advantage of sustained drug release are the prime factors that drive the growth of this segment.Regarding geographic distribution, North America, Europe, Asia-Pacific, the Middle East, Africa, and Latin America comprise the global drug delivery technologies market.

North America and Europe capture over 60% of the global drug delivery technologies market revenue. The adoption of novel non-oral drug administration modes such as transdermal, implantable, and pulmonary drug delivery is rapid and large-scale in North America. Products such as dry powder inhalers, pen injectors for seasonal allergies, orodispersable tablets, and other control-release products are in high demand in developed markets. The use of implantable devices such as eluting drug stents is increasingly used in treating chronic illnesses and for contraception.

Moreover, major players in the developing drug delivery technologies are primarily domiciled in Europe and U.S., thus giving the regions an early bird advantage in terms of rapid product adoption. A high awareness level among caregivers and patients also significantly contributes to the above trend. Intense competition among drug manufacturers and the growing trend of outsourcing manufacturing processes have fragmented this market, with numerous players developing newer drug delivery formulation technologies. This report also studies the global drug delivery technologies market at a major national and regional level.

Frequently Asked Questions:

The market for Drug Delivery Technologies is expected to reach US$ XX Mn by 2022.

The Drug Delivery Technologies market is expected to see significant CAGR growth over the coming years, at XX%.

The report is forecasted from 2015 to 2022.

The base year of this report is 2014.

Bayer AG, Business Description, Financial Health and Budget Allocation, Product Positions/Portfolio, News Coverage are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Apr 2016
Category:  Medical Devices
Report ID:   57779
Report Format:   PDF
Pages:   120
Rating:    4.2 (55)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support